COEP - Coeptis Therapeutics Holdings, Inc.
9.3
0.050 0.538%
Share volume: 19,177
Last Updated: 04-08-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.07%
PREVIOUS CLOSE
CHG
CHG%
$9.25
0.05
0.01%
Fundamental analysis
21%
Profitability
0%
Dept financing
24%
Liquidity
24%
Performance
40%
Performance
5 Days
-3.83%
1 Month
-14.68%
3 Months
22.85%
6 Months
5,133.54%
1 Year
2,291.36%
2 Year
604.55%
Key data
Stock price
$9.30
DAY RANGE
$9.07 - $9.49
52 WEEK RANGE
$0.13 - $13.70
52 WEEK CHANGE
$2,284.62
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
Company detail

CEO: David Mehalick
Region: US
Website: coeptispharma.com
Employees: 2
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Region: US
Website: coeptispharma.com
Employees: 2
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing
Bull Horn Holdings Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded in 2018 and is based in Miami Beach, Florida.
Recent news
